These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2953085)

  • 1. V1a-vasopressin specific receptors on human platelets: potentiation by ADP and epinephrine and evidence for homologous down-regulation.
    Launay JM; Vittet D; Vidaud M; Rondot A; Mathieu MN; Lalau-Keraly C; Cantau B; Chevillard C
    Thromb Res; 1987 Feb; 45(4):323-31. PubMed ID: 2953085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of human platelet vasopressin receptor and the relation between vasopressin-induced platelet aggregation and vasopressin binding to platelets.
    Inaba K; Umeda Y; Yamane Y; Urakami M; Inada M
    Clin Endocrinol (Oxf); 1988 Oct; 29(4):377-86. PubMed ID: 2978018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of two steps in the homologous desensitization of vasopressin-sensitive phospholipase C in WRK1 cells. Uncoupling and loss of vasopressin receptors.
    Cantau B; Guillon G; Alaoui MF; Chicot D; Balestre MN; Devilliers G
    J Biol Chem; 1988 Jul; 263(21):10443-50. PubMed ID: 2968982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA; Albrecht RM
    Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine vasopressin release from human platelets after irreversible aggregation.
    Anfossi G; Mularoni E; Trovati M; Massucco P; Mattiello L; Emanuelli G
    Clin Sci (Lond); 1990 Jan; 78(1):113-6. PubMed ID: 2153488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epinephrine potentiates human platelet activation but is not an aggregating agent.
    Lanza F; Beretz A; Stierlé A; Hanau D; Kubina M; Cazenave JP
    Am J Physiol; 1988 Dec; 255(6 Pt 2):H1276-88. PubMed ID: 3202191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular localization of vasopressin-like material in platelets.
    Chesney CM; Crofton JT; Pifer DD; Brooks DP; Huch KM; Share L
    J Lab Clin Med; 1985 Sep; 106(3):314-8. PubMed ID: 3928782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homologous regulation of human platelet vasopressin receptors does not occur in vivo.
    Vittet D; Launay JM; Chevillard C
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1400-5. PubMed ID: 2532481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation and vasopressin receptors in patients with diabetes mellitus.
    Thibonnier M; Woloschak M
    Proc Soc Exp Biol Med; 1988 Jun; 188(2):149-52. PubMed ID: 2967499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADP, adrenaline and serotonin stimulate inositol 1,4,5-trisphosphate production in human platelets.
    Vanags DM; Lloyd JV; Rodgers SE; Bochner F
    Eur J Pharmacol; 1998 Sep; 358(1):93-100. PubMed ID: 9809874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. Importance of pseudopods.
    Milton JG; Frojmovic MM
    J Lab Clin Med; 1984 Nov; 104(5):805-15. PubMed ID: 6387013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epinephrine-induced aggregation of rabbit platelets refractory to ADP.
    Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human platelet vasopressin receptors.
    Thibonnier M; Roberts JM
    J Clin Invest; 1985 Nov; 76(5):1857-64. PubMed ID: 2997293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of platelet responses in vitro by feline infectious peritonitis virus.
    Boudreaux MK; Weiss RC; Toivio-Kinnucan M; Spano JS
    Vet Pathol; 1990 Jul; 27(4):261-8. PubMed ID: 2144930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate.
    Pearce PH; Wright JM; Egan CM; Scrutton MC
    Eur J Biochem; 1978 Aug; 88(2):543-54. PubMed ID: 689037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein phosphorylation and diglyceride production during serotonin release induced by epinephrine plus ADP in human platelets.
    Kawahara Y; Yamanishi J; Tsunemitsu M; Fukuzaki H
    Thromb Res; 1983 Jun; 30(5):477-85. PubMed ID: 6612681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
    Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets.
    Brass LF; Shattil SJ
    J Clin Invest; 1984 Mar; 73(3):626-32. PubMed ID: 6231306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some properties of the human platelet vasopressin receptor.
    Thomas ME; Osmani AH; Scrutton MC
    Thromb Res; 1983 Dec; 32(6):557-66. PubMed ID: 6320489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.